Ketogenic Diet Against Liver Tumor

Abstract

Abstract Objectives Report my experience in treating two liver tumor patients with ketogenic diet KD protocol as monotherapy. In addition to the two patients who enrolled in this study, I also reviewed findings from 10 other patients, including 2 patients from case reports. Methods The ketogenic diet consists of high fat foods, foods that contain an adequate amount of protein, and a very low amount of carbohydrates. Normally, the body gets its main source of energy (sugar) from carbs. However, the ketogenic diet deprives the body of glucose, inducing a state of “ketosis.” During ketosis, the body is forced to break down stored fat instead of sugar to produce an alternative source of energy. Results The two patients who enrolled in my KD pilot study were monitored with twice daily measurements of blood glucose and ketones. Within 30 days of initiating the KD blood glucose levels declined to low-normal levels and blood ketones were elevated. Results of ultrasound images indicated that tumors has gone 1 year after KD. One patient exhibited significant clinical improvements during the study. All of these patients was treated using KD as monotherapy. No major side effects due to KD have been reported in any of these patients. They continued the ketogenic diet remaining free of disease progression. Conclusions I conclude that: 1. KD is safe and without major side effects; 2. ketosis can be induced using customary foods; 3. treatment with KD may be effective in controlling the progression of some liver cancer cells; 4. Maybe we can manipulate our own biological system a little bit or activate something we already have in place in order to more effectively combat cancer. Funding Sources DoTerra Science.